Tratamiento en Milán (Italia)

Dr. Paola Maria Magnoni has graduated in general medicine and radiodiagnostics at Università degli Studi of Milan and is the Ultrasound Unit Director of Humanitas Research Hospital, where she dedicates especial attention to internal, oncological, breast, endocrinology and loop ultrasound, performing over 5000 examinations of which 500 needle biopsy annually.

Medical areas of interest: Ultrasound in all its fields of use, especially:

Diagnostic ultrasound: internal, oncological, intestinal loops, endocrinology.

Interventional ultrasound: superficial needle biopsies of areas such as breast, thyroid, soft parts; and deep needle biopsies of areas such as abdominal organs, liver, kidney pancreas; retroperitoneum; paracentesis, thoracentesis, drainage and inflections.

Research areas of interest: sarcomas, early diagnosis in oncological pathologies, iconographic study of IBD, senology, endocrinology.

Prof. Eduardo Nobile Orazio is the Neurology Unit Director in Humanitas Research Hospital. 

His main areas of interest and specialisation are: diagnosis and treatment of neuromuscular diseases, in particular polyneuropathies, also including those of immunological origin such as Guillain Barré Syndrome (GBS) and the different clinical variants, chronic inflammatory demyelinating polyneuropathy (CIDP), multifocal motor neuropathy (MMN), and the polyneuropathies associated with monoclonal gammopathy, the neuropathies and paraneoplastic neuronopathies and neuropathies in the course of haematologic diseases and from chemotherapy. 

Immunological diagnosis of autoimmune diseases of the peripheral and central nervous system, diagnosis and treatment of motor neurone disease with suspected paraneoplastic or immune genesis, diagnosis and treatment of Multiple Sclerosis and other autoimmune and inflammatory diseases of the central nervous system such as autoimmune and paraneoplastic encephalitis, diagnosis and treatment of Parkinson’s Disease and extrapyramidal diseases.

His areas of research are clinical and immunological diagnosis and treatment of the immune mediated polyneuropathies and, in particular, GBS, CIDP, MMN and polyneuropathy associated with monoclonal gammopathy including POEMS.

Prof. Eduardo Nobile Orazio has written over 230 scientific publications, held more than 85 university seminars or conferences. He has been a member of the SIN since 1991, of the European Neurological Society since 1989 until 2014, when he joined the European Academy of Neurology. Prof. Eduardo Nobile Orazio has also been a member of the American Academy of Neurology since 1998 and of the American Neurological Association since 2012.

Publications: http://www.ncbi.nlm.nih.gov/pubmed/?term=Nobile-Or  

Prof. Nicola Portinaro is the Director of the Orthopaedic Paediatric and neuro-orthopaedic Unit at Humanitas Research Hospital, and is Professor of Orthopaedics and Traumatology at the University of Milan. 

He was appointed as Fellow of the Royal College of Surgeons, Edinburgh, and from 2000 until now, Honorary Special Senior Lecturer at University of Bristol, UK. Founder and Scientific Director of "Ariel Foundation", a non profit foundation for pediatric neurological disabilities founded in 2002. 

The team of Professor Portinaro is one of the internationally recognized leading teams in the field of paediatric orthopaedics and neuro-orthopaedic surgery with an experience of over 100 bone surgerical procedures on lower limb every year, including 50 pelvic osteotomies and more than 300 surgical procedures on muscles and tendons (lightening, transfer…). He is specialized in the treatment of lower and upper limb deformities related to Cerebral Palsy, Spina Brifida, Developmental Dysplasia of the Hip, Perthes Disease, clubfoot and alteration in skeletal development. 

A considerable part of his activity is in scientific research, with several experimental works with the goal of detecting uknown anchors aspects of diseases treated by him. His research fields include the study of genomic and proteomic of extracellular matrix proteins in different diseases. 

Publications: http://www.ncbi.nlm.nih.gov/pubmed/?term=portinaro 

Prof. Marco Montorsi is the Director of the Department of General and digestive surgery unit in Humanitas Research Hospital and he is Professor of General Surgery at the Humanitas University. His academic career started in the the Humanitas University of Milan, where he entered in 1980 as Assistant Professor and was appointed as Professor of Surgery in 2001.

His main interests are in the field of digestive diseases and in the surgical treatment of the related pathologies, mainly hepatico-pancreatico-biliary (HPB) and colorectal pathologies. He is indeed the Director of the Department of Surgery in Humanitas Research Hospital where a great volume of major abdominal surgeries is routinely performed. Around 250 -300 hepatic and pancreatic resections and 350 colorectal resections.
He began performing laparoscopic colorectal surgery in the early 90s and gained a lot of experience in this field. The vast majority of colorectal tumours diagnosed in the department of Surgery is submitted to laparoscopic resection thus allowing a smooth and safe disease course. A robotic approach with the new Da Vinci equipment is now available for patients with rectal tumours.

Transanal endoscopic microsurgery (TEM) with dedicated instruments is also offered to selected patient with low-sited rectal tumours so sparing major abdominal approach.

A routine policy of strict interaction with the Dept. of Oncology is active for patients needing a perioperative chemo- and radiotherapy with the aim of full integration for a better care and results.

Prof. Marco Montorsi is also Humanitas University President with over 10 years of experience in didactic and clinic teaching to medical students.

Publications: http://www.ncbi.nlm.nih.gov/pubmed/?term=montorsi+marco

Dr. Lucia Torracca is leading the Cardiac Surgery Unit at Humanitas Research Hospital. She received her training at Ospedali Civili di Brescia and at Ospedale San Raffaele with Professor Ottavio Alfieri, were she improved her knowledge in the mitral disease focusing in the reparative and preservative approaches. At the same institution she led the minimal invasive and robotic division before moving to Ospedali Riuniti Di Ancona to be chief of the Cardiac Surgery Complex Unit. Dr. Torracca has performed more than 55 hundred cardiac surgeries. Thanks to her surgical and academic curriculum, she has been an active member of the steering committee of the European Society editing Guidelines for the treatment of heart diseases.

Together with her team in Humanitas, she can approach every cardiac disease affecting adults, especially focusing on the minimal invasive approach to reparative valve disease. State of the art technologies are regularly explored and implemented in the Open Heart dedicated Operating Room and Intensive Care Unit to ensure best outcomes, shorter hospital stay and fewer surgical complications.

The surgical expertise of Dr. Torracca go from open heart circulatory-arrest procedure to off-pump and/or trans-catheter procedures (MitraClip or TransApical Aortic Valve Implants).

Dr. Torracca and her team can claim the highest rate of mitral valve repair in Bi-leaflet prolapse (Barlow Disease) hitting almost 99% of conservative approach in minimal invasiveness at the time of surgery, maintaining >95% success rate at long term follow up: this option is further advantageous in the youngest patient population allowing restrain from anticoagulation therapy and perfectly normal quality of life.

Author or co-author of 151 publications in national and international scientific journals.

Prof. Leonardo Maradei is specialised in orthopaedics and traumatology and is the Director of the Foot Surgery and Minimally Invasive Operations Unit in Humanitas Research Hospital. 

Prof. Leonardo Maradei performs surgery on the foot with minimally invasive techniques and arthroscopic surgery. After his specialization he deepened his studies in arthroscopic surgery of the shoulder and the knee at the Mississippi Sports Medicine & Orthopaedic Center (USA), under the guidance of prof. F. H. Savoie. He has developed considerable experience in shoulder prosthetic surgery as a pupil of prof. Mario Randelli. 
His research is focused on the development of new prosthetic materials for the shoulder. During his years in Humanitas he has performed more than 2000 surgeries on the foot, more than 1000 on the knee and more than a 1000 on the shoulder. 

Dr. Maradei is a professor at Università Statale of Milan where he teaches Medicine and Surgery - Lessons on minimally invasive surgery of the shoulder and knee.

Publications: http://www.ncbi.nlm.nih.gov/pubmed/?term=maradei+leonardo

Dr. Federico Pessina is the Cranial Neurosurgey Unit Director.

Medical areas of interest: Brain tumors, glioblastomas, low grade gliomas, brain metastases, meningiomas, neuromas, cavernous angiomas, brain aneurysms

Surgical treatment with brain mapping techniques, awake and minimally invasive surgery of all central nervous system tumors.

Surgical treatment of highly complex tumors of the skull base and cranio-cervical hinge: meningiomas, neuromas, craniopharyngiomas, brain stem tumors.

All the tumor pathologies described above are addressed after multidisciplinary multi-specialist evaluation.

The surgical approach is customized to the patient and to the type of lesion, making use of the most advanced intraoperative techniques for malignant brain tumors (neuronavigation, intraoperative neurophysiology, intraoperative CT) and more complex approaches (anterior, posterior and combined petroosectomies, minimally invasive accesses) for benign diseases of the skull base such as meningiomas and neuromas.

Research areas of interest: Experimental protocols in the treatment of glioblastomas

- Prospective protocols in the treatment of brain metastases

- Role of surgical removal and integrated treatments in glioblastomas and malignant brain tumors

- Intracranial meningiomas

- Cadaver lab dissection

Author of more than 60 scientific publications and 5 book chapters, he is member of Italian Society of Neurosurgery (SINCH).

In 2018 he joined the Scientific Committee of European Society of Neuroncology (EANO) and the Skull Base Surgery Committee of World Federation of Neurosurgical Society (WFNS).

Specialized training: 

Prof. Pessina obtained his Degree in Medicine and Surgery in University of  Insubria,  Varese, where he also completed his Residency Program.

From 2007 to 2008 he covered the role of Clinical Fellow in Neurosurgery in Lausanne University Hospital, focusing on image-guided intrinsic brain tumors resection and vascular neurosurgery

In 2018 he covered the Skull Base fellow position in Lariboisiere Hospital, Paris, fully dedicating to skull base surgery and hands-on dissection practice and teaching.

Since 2022, he is Full Professor in Neurosurgery (MED/27) in Humanitas University

Additional information of interest:

Member of the Scientific Committee of the European Association of Neuroncology (EANO)

Publications:  https://www.ncbi.nlm.nih.gov/pubmed/?term=Pessina+Federico

Dr. Corrado Lodigiani has been assistant at the Thrombosis Centre of Humanitas research Hospital from 1998 to 2013 and he became Unit Director in 2013. 

Humanitas Thrombosis Center is a state-of-the-art service for the proper management of the diagnosis and therapy of venous thromboembolic pathology (deep and superficial venous thrombosis, pulmonary thromboembolism, visceral venous thrombosis) and arterial (myocardial infarction, cerebral stroke, peripheral arterial disease). 
Other also rare diseases treated are atypical thrombosis, such as the vascular circulation of the retina, the hearing system and the placental circulation during pregnancy. 

Dr. Lodigiani adopts the multidisciplinary approach and works in collaboration with all medical and surgical specialties. In particular, he carries out clinical and instrumental diagnostics (vascular ecocolordoppler) and research on the causes, diagnosis and therapy of thrombotic and bleeding disorders, congenital and acquired. His clinical activity also involves the diagnosis and management of patients suffering from bleeding diseases, such as haemophilia, von Willebrand’s disease and platelet diseases.

Medical areas of interest:  

In recent years, he has devoted himself with particular interest to the testing, in the role of Principal Investigator in International Clinical Studies, of new antithrombotic drugs and, above all, anticoagulants, which are about to be marketed and will constitute a valid and safe alternative to traditional oral anticoagulant therapy (DOACs). He is also working, with great interest, on researching the causes of idiopathic infertility and the usefulness and effectiveness of some therapeutic strategies, such as the use of anticoagulant drugs, improving the results of artificial insemination procedures. He is the author of numerous articles in international scientific journals and speaker at numerous national and international conferences.

Prof. Andrea Lania has graduated at the Università degli Studi of Milan and is specialized in endocrinology. He is the Unit Director of Endocrinology and Diabetology in Humanitas Research Hospital and his specialization is pituitary diseases, pituitary adenomas, thyroid cancer, pancreatic neuroendocrine tumors, poorly differentiated neuroendocrine carcinomas.

Medical areas of interest:
Pituitary tumors, hypopituitarism, acromegaly, Cushing’s disease and syndrome, neuroendocrine tumors, thyroid and thyroid diseases, adrenal and adrenal diseases, hypogonadism.

Research areas of interest:
Study of the pathogenetic mechanisms of pituitary and neuroendocrine tumors, of the molecular mechanisms responsible for the different response of pituitary and neuroendocrine tumors to medical therapy.

Prof. Lania published 198 peer-reviewed papers (Google Scholar H-Index 47; Scopus H-Index 38, cit tot 4604)

Prof. Lania has a long standing expertise in the field of intra-cellular signaling in endocrine tumors. In particular, in the past ten years, he contributed to analyze the role of PKA regulatory subunits in the pathogenesis and control of cell proliferation of endocrine tumors. Moreover, he contributed to define the role of SSTR5 domains involved in the intracellular trafficking of this receptor in human pituitary cells and to analyze the impact of DR2R and SSTR2&5 polymorphic variants on both the clinical outcome and response to medical treatment in patients with pituitary tumors.

Recently, he contributed to identify the role of cytoskeleton protein FLNA in mediating both intracellular signaling and membrane targeting of somatostatin type 2 receptor and D2R in pituitary and pancreatic neuroendocrine tumors. Finally, he contributed to explore the intracellular mechanisms possibly involved in mediating the interplay between drugs commonly used in the treatment of neuroendocrine tumors.

Previous experience:
2005-2008 Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy
Director of Endocrinologic Day Hospital and surgery on pituitary disorders. 

Publications: https://www.ncbi.nlm.nih.gov/pubmed?term=lania%20A 

Prof. Alessandro Repici is the Director of the Gastroenterology and Digestive endoscopy Unit in Humanitas Research Hospital. Graduated in Medicine and Surgery in 1990 and the following year he won a scholarship at the Department of Gastroenterology Molinette hospital in Turin, where he began his practice in digestive endoscopy. In 1992, he worked with Prof. Claude Liguory as a fellow at the American Hospital in Paris.

In 1994 he became a specialist in Gastroenterology and Digestive Endoscopy at the University of Messina and worked in the Department of Gastroenterology, Ospedale Maggiore Molinette of Turin.

In the following years, he has been working at the Service of Digestive Endoscopy of Altona Hospital in Hamburg, directed by prof. Hagenmuller, and in the Department of Gastroenterology Molinette Hospital in Turin, directed by prof. Rizzetto. In 1999, he was a Research Fellow at the Center for Oncological and Operative Endoscopy of Wellsley Hospital in Toronto.

He teaches Gastroenterology and Digestive Endoscopy at the School of Specialization in Oncology since 2000, at the University of Turin since 2004 and Endoscopy Diagnostic Techniques and Operations at the School of Specialization in General Surgery I and II of the University of Turin.

The clinical activity and research of Prof. Repici mainly focuses on the development of new endoscopic techniques in the field of diagnosis and therapy, with particular attention to new methods of endoscopic removal of cancerous lesions and early in the palliation of advanced gastrointestinal malignancies.

Prof. Repici is coordinator, principal investigator and co-investigator in more than 50 studies, including phase II and III for FDA and EMA approval of new molecules and new instruments for diagnostic and operational endoscopy. 

Prof. Repici collaborates on research projects in the field of endoscopy with the University of Rotterdam, in Haifa, in New York and with several Italian centers. He is a member of various national and international scientific society of Gastroenterology and Digestive Endoscopy.

Publications: http://www.ncbi.nlm.nih.gov/pubmed/?term=repici+alessandro

Dr. Bernhard Reimers – Clinical and Invasive Cardiology Unit Director in Humanitas Research Hospital, was born in Germany. He graduated in medicine and surgery in University of Padua (Italy) in 1990, followed by specialization in Cardiology. During the first 3 years of specialization in Cardiology in the Coronary Unit of Padua University, his particular interests were in managing cardiovascular urgency and critical patients, including management of fans, balloon pump, hemofiltration, temporary pacing, placement of central venous pathways and Swan-Ganz catheter. He spent his last year of specialization at the Hemodynamics of Casa di Cura Columbus (Milan), where he acquired his knowledge on the main diagnostic techniques he uses. After a short period of study at the Thoraxcenter of Rotterdam, during which he wrote his first scientific publications, Dr. Reimers has dedicated himself to hemodynamics and cardiovascular surgeries, working as Unit Director main assistant, executing angioplasty, coronary and peripheral procedures, reaching complete autonomy in coronary stenting, atherectomy, ultrasound intravascular and intracoronary doppler.

Since September 1997 he has managed and developed the diagnostic and interventional cardiovascular program at the Department of Cardiology of Mirano (Venice), where, thanks to his achievements, since 2000 the highest number of coronary angioplasties were performed. In 2006 the Unit has performed 975 coronary angioplasties (including 125 primary), more than 400 carotid angioplasty and peripherals. Dr. Reimers became Unit Director and has trained and taught a young team of interventional cardiologists, including 4 completely independent in the performance of coronary angioplasty, which manages both hemodynamics and largely the CCU in close collaboration between the two services. After this important experience, he was invited to be part of Humanitas Research Hospital as Clinical and Invasive Cardiology Unit Director.

Dr. Reimers participates in many scientific studies on the treatment of myocardial infarction considering new interventional or pharmaceutical approaches for primary angioplasty. He was also member of the Technical Commission of the Regional Bid for the purchase of stents. Thanks to Dr. Reimers’ efforts, Hemodynamics of Mirano (Venice) is considered reference center for primary angioplasty and elective complex procedures. Dr. Reimers is considered to be one of the leading experts of carotid angioplasty worldwide. He is preparing a program for interventional treatment of acute stroke. He performs routine renal angioplasty and implants percutaneous devices and endoprosthesis systems for aortic aneurysms.

Dr. Reimers has published, as author or co-author, 77 articles quoted in Medline. The impact factor calculated based on 2006 is 263. He published 9 book chapters and several abstracts for important international conferences dedicated to Cardiology, such as TCT, PCR, National GISE ANMCO, JIM and ESC, were he also performed live invasive procedures.

Dr. Reimers has always considered participation in clinical trials and scientific international events among the main activities of his professional carrier. Besides teaching at University of Tor Vergata in Rome, he organizes many conferences, national and international medical follow-up courses. For over 9 years he has been organizing theoretical and practical courses with lectures and transmission of live procedures in Venice. He has so far organized two editions of TOBI, international meeting dedicated to invasive treatment of total coronary occlusions and bifurcations, three editions of ETI, international conference and the largest in Italy, dedicated to invasive cardiology devices. 

Dr. Reimers was member of the scientific committee in the editions of 2006 and 2007 of National Convention GISE (Italian Group of Hemodynamic Study) and participated at important events dedicated to CAPTURE study, ESIRIUS, SYNTAX, TIMI 38, FINESSE and many others.

Publications: ttp://www.ncbi.nlm.nih.gov/pubmed/?term=bernhard

Prof. Marco Klinger is director of the School of Specialization in Plastic, Reconstructive and Aesthetic Surgery at the University of Milan and Head of the Operating Unit in Plastic, Reconstructive and Aesthetic Surgery at Humanitas Research Hospital.

He specializes in plastic and reconstructive surgery: treatment of scars, burns, outcomes of bariatric surgery, regenerative medicine and surgery, post-oncological breast reconstruction, breast malformations and skin oncology. Aesthetic plastic surgery: augmentation mammoplasty, mastopexy, reduction mammoplasty, rhinoplasty/ rhinoseptoplasty, lifting, liposuction, abdominoplasty, blepharoplasty and otoplasty.

Research interests: Regenerative medicine and surgery.

Prof. Klinger and his team have performed more than 35,000 plastic surgery and reconstructive surgery; he is the author of over 200 scientific articles, published in national and international journals. Among his most recent and significant studies, the use of lipofilling in treatment of severe burn outcome, scleroderma and chronic pain syndromes, such as Post Mastectomy Pain Syndrome.

Scientific publications: 

http://www.ncbi.nlm.nih.gov/pubmed?term=klinger%20marco

El Director de la Clínica Doctor's Equipe. El inventor del sistema Microfat. Especialista en Cirugía Maxilofacial y Corrección Estética Cosmética.

El Dr. Mohssen Ansarin es oncólogo especializado en cáncer de cabeza y cuello y es miembro fundador de SRS y AIOCC. Es autor y coautor de más de 50 artículos, y actualmente es el editor en jefe de ACTA Otolaryngologica.

Filippo de Marinis es Director de la Unidad de Oncología Torácica del Centro Europeo del Cáncer (Milán, Italia). El médico dirige ensayos clínicos de nuevos métodos en el tratamiento de tumores malignos del tórax.

La experiencia del médico es de más de 30 años.

En 1978, de Marinis completó sus estudios de neumología en la Universidad Sapienza de Roma. Entre 1983 y 1986 se especializó en oncología en la Universidad Católica del Sagrado Corazón de Roma. Después, Filippo de Marinis trabajó como médico en el Hospital Carlo Forlanini y en el Instituto de Ensayos Clínicos e Investigaciones Neumofisiológicas. Desde 2007, enseña neumología en la universidad privada de Roma “Campus Biomedico” (“Campus Biomedico”) y en la Universidad Sapienza de Roma. Desde 2013, el profesor es el jefe del Departamento de Cáncer Torácico del Centro Europeo del Cáncer.

Cita con el médico

Una cita con Filippo de Marinis dura de 40 a 60 minutos. Durante este tiempo, el médico recopila el historial médico del paciente y lo compara con los resultados del examen. Para establecer un diagnóstico preciso o planificar una operación, el médico prescribirá pruebas adicionales si es necesario.

Actividad científica

El profesor de Marinis es autor de 250 publicaciones científicas en 130 publicaciones médicas. Como uno de los mejores especialistas en el tratamiento del cáncer de pulmón, ha sido ponente en 300 congresos científicos en los últimos 5 años.

El médico participa en ensayos clínicos nacionales e internacionales de nuevos medicamentos.

Membresía en organizaciones

• AIOT - Asociación Italiana de Cáncer Torácico;
• ESMO - Sociedad Europea de Oncología Médica;
• ASCO - Sociedad Americana de Oncología Clínica;
• IASLC - Asociación Internacional para el Estudio del Cáncer de Pulmón;
• ETOP - Plataforma Europea de Oncología Torácica.

Barbara Alicia Erechek es Directora del Departamento de Radioterapia del Centro Europeo del Cáncer en Milán y Profesora de Oncología Radioterápica en la Universidad de Milán. El médico se especializa en radioterapia para todo tipo de cáncer y tumores metastásicos.

• 26 años de experiencia en radioterapia;
• 140 publicaciones científicas.

La profesora Erechek recibió su título de médico en la Universidad de Gdansk (Polonia) en 1992. Mejoró sus calificaciones en el campo de la oncología radioterápica en el Instituto Oncológico de Varsovia, la Universidad de Milán, el Centro de Cáncer Beatson en la Universidad de Glasgow (Reino Unido). Desde 1997, el médico trabaja como especialista en radioterapia en el Centro Europeo del Cáncer. Desde 2015, es la jefa del departamento de radioterapia de la clínica.

Cita con el médico

Una cita con el Dr. Erechek para la planificación de la radioterapia tarda entre 30 y 50 minutos. El médico examina los registros médicos del paciente y los resultados de las pruebas. Ella explica el diagnóstico, habla sobre cómo se llevará a cabo el tratamiento posterior. El médico da recomendaciones sobre la mejor manera de prepararse para el curso de los procedimientos para que sean más cómodos.

Para obtener una consulta del profesor Erechek, deje una solicitud en el sitio web de Bookimed. El coordinador médico se pondrá en contacto con usted para acordar la fecha y hora de la consulta.

Actividad científica

La profesora Bárbara Alicia Erechek es autora de 140 publicaciones científicas.

Logros profesionales y premios.

Entre 1999 y 2003, el Prof. Jereczek recibió 4 premios de la Universidad Médica de Gdańsk por investigaciones en el campo de la oncología y la radioterapia.

Membresía en organizaciones

• ESTRO - Sociedad Europea de Oncología y Radiología Terapéutica;
• AIRO - Sociedad Italiana de Oncología Radioterápica;
• Comité de Revisión de Nuevos Protocolos del Instituto Europeo de Oncología, Milán, Italia;
• Comité de Calidad de Ensayos Clínicos del Instituto Europeo de Oncología, Milán, Italia.

Cirujano, senólogo

Oncólogo-urólogo

El Dr. Giuseppe Curigliano es el jefe de la División de Desarrollo Temprano de Fármacos en el Instituto Europeo de Oncología y Profesor Asociado de Oncología Médica en la Universidad de Milán en Italia. Es miembro fundador y presidente científico de la Sociedad Internacional de Cardio-Oncología (ICOS) y recibió el primer Premio Umberto Veronesi de ESO en Viena en 2017 y la Beca de la Academia Europea de Ciencias del Cáncer en París en 2017.

Nicoletta Colombo es directora del Ovarian Cancer Center en IEO, es autora de numerosas publicaciones en el campo de la oncología ginecológica y es miembro de ASCO, SGO e IGCS.